🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsPatient preference: weekly injection vs potential monthly depot — July 2024 Page 3

Patient preference: weekly injection vs potential monthly depot — July 2024

Dr.PainCLE Tue, Jan 9, 2024 at 8:16 AM 15 replies 2,193 viewsPage 3 of 3
tom_AK
New Member
28
112
Jan 2026
Anchorage, AK
Jan 9, 2024 at 12:31 PM#11
julia.endo said:
Patient preference weekly injection is not that straightforward in my experience

This is exactly right. julia.endo articulated what I have been trying to explain to my friends for months. The Patient preference weekly aspect is what made the difference for me.

Last edited: Jan 9, 2024 at 4:31 PM
26 23steve_okc, dave_SLC, FDA_TrackerJim and 23 others
Reply Quote Save Share Report
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Jan 9, 2024 at 12:48 PM#12

Reading this thread on Patient preference weekly hits close to home. Dad of 2 checking in — I started at 285 lbs and felt like I would tried everything.

11 months on tirz and I am a different person. Not just the 60 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Patient preference — take the leap. It was the best health decision I have ever made. ❤️

13 4lucas_SP_BR, lisa_labSD, adam_van and 10 others
Reply Quote Save Share Report
CryptoCarl
Member
789
3,456
May 2024
Arizona
Jan 9, 2024 at 1:05 PM#13

Dr.ReproEndo — that is really helpful context on Patient preference weekly. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

Last edited: Jan 9, 2024 at 5:05 PM
3 3AussieAnna, BethLabQueen, ChrisMacros
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Jan 9, 2024 at 1:22 PM#14

To answer InsuranceTom's question specifically:

From a clinical standpoint, Patient preference weekly is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

Last edited: Jan 9, 2024 at 3:22 PM
27 11TomFromTexas, mike.trainer_LA, sarah_nash92 and 24 others
Reply Quote Save Share Report
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Jan 9, 2024 at 1:39 PM#15

Bookmarked 📌 The Patient preference info in this thread is essential. Coming back to this for sure.

Last edited: Jan 9, 2024 at 6:39 PM
12 22LarryQC_SD, wanda_boise, NurseAsh_DET and 9 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register